NewGenIvf Group (NewGenIvf Group) EBIT : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is NewGenIvf Group EBIT?

NewGenIvf Group's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was $0.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NewGenIvf Group's annualized ROC % for the quarter that ended in Jun. 2023 was 0.00%. NewGenIvf Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. NewGenIvf Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 0.00%.

NewGenIvf Group EBIT Historical Data

The historical data trend for NewGenIvf Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewGenIvf Group EBIT Chart

NewGenIvf Group Annual Data

Trend

Dec21

Dec22

EBIT

0.24

0.42

NewGenIvf Group Quarterly Data
	Dec21	Jun22	Dec22	Jun23
EBIT	-	-	-	-

Competitive Comparison of NewGenIvf Group's EBIT

For the Medical Care Facilities subindustry, NewGenIvf Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewGenIvf Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NewGenIvf Group's EV-to-EBIT falls into.

NewGenIvf Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

NewGenIvf Group (NAS:NIVF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NewGenIvf Group's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2022 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	0 * ( 1 - % )	/	( (2.07	+	0.712)	/ 2 )
=	0	/	1.391
=	0.00 %

where

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.905	-	0.992	-	( 0.028	-	max(0, 2.556	-	2.399	+	0.028	))
=	2.07

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1.45	-	1.035	-	( 0.077	-	max(0, 1.341	-	1.044	+	0.077	))
=	0.712

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

NewGenIvf Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2022		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0	/	( ( (0.506 + max(-2.293, 0))	+	(0.406 + max(-0.984, 0)) )	/	2 )
=	0	/	( ( 0.506	+	0.406 )	/	2 )
=	0	/	0.456
=	0.00 %

where Working Capital is:

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.013	+	0.047	+	0)	-	(0.992	+	1.36	+	0.00099999999999989)
=	-2.293

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.092	+	0.068	+	0.0010000000000001)	-	(1.035	+	0.109	+	0.0010000000000001)
=	-0.984

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

NewGenIvf Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	0	/	12.151
	=	0.00 %

NewGenIvf Group EBIT Related Terms

Thank you for viewing the detailed overview of NewGenIvf Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

NewGenIvf Group (NewGenIvf Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NewGenIvf Group Ltd (NAS:NIVF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110

Website

https://www.newgenivf.com

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

NewGenIvf Group (NewGenIvf Group) Headlines

From GuruFocus

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

By Marketwired • 04-22-2024